- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases - Abstract
September 12, 2013
Predictive value of serum bone sialoprotein and prostate-specific antigen doubling time in patients with bone metastasis of prostate cancer - Abstract
September 11, 2013
Evidence for the efficacy of enzalutamide in postchemotherapy metastatic castrate-resistant prostate cancer - Abstract
September 11, 2013
The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer - Abstract
September 11, 2013
Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis - Abstract
September 11, 2013
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty - Abstract
September 11, 2013
Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: Initial single institution experience - Abstract
September 11, 2013
Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: Implications for the use of newer isotopes - Abstract
September 11, 2013
Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer - Abstract
September 11, 2013
Metastatic castration-resistant prostate cancer: Two case reports of dramatic response with abiraterone acetate in patients heavily pretreated with chemotherapy - Abstract
September 10, 2013
A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer - Abstract
September 10, 2013
Pleuropulmonary and lymph node progression after docetaxel - Benefits from treatment with cabazitaxel in metastatic prostate cancer - Abstract
September 10, 2013